| Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma O Zavidij, NJ Haradhvala, TH Mouhieddine, R Sklavenitis-Pistofidis, S Cai, ... Nature cancer 1 (5), 493-506, 2020 | 253 | 2020 |
| Efficacy and safety of nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma NM Tannir, S Signoretti, TK Choueiri, DF McDermott, RJ Motzer, A Flaifel, ... Clinical Cancer Research 27 (1), 78-86, 2021 | 186 | 2021 |
| Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival MG Oser, R Fonseca, AA Chakraborty, R Brough, A Spektor, RB Jennings, ... Cancer discovery 9 (2), 230-247, 2019 | 138 | 2019 |
| Results of a multicenter phase II study of atezolizumab and bevacizumab for patients with metastatic renal cell carcinoma with variant histology and/or sarcomatoid features BA McGregor, RR McKay, DA Braun, L Werner, K Gray, A Flaifel, ... Journal of Clinical Oncology 38 (1), 63, 2020 | 126 | 2020 |
| The clinical activity of PD-1/PD-L1 inhibitors in metastatic non–clear cell renal cell carcinoma RR McKay, D Bossé, W Xie, SAM Wankowicz, A Flaifel, R Brandao, ... Cancer immunology research 6 (7), 758-765, 2018 | 114 | 2018 |
| Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma Z Bakouny, DA Braun, SA Shukla, W Pan, X Gao, Y Hou, A Flaifel, S Tang, ... Nature communications 12 (1), 808, 2021 | 100 | 2021 |
| irRECIST for the evaluation of candidate biomarkers of response to nivolumab in metastatic clear cell renal cell carcinoma: analysis of a phase II prospective clinical trial JC Pignon, O Jegede, SA Shukla, DA Braun, CE Horak, M Wind-Rotolo, ... Clinical Cancer Research 25 (7), 2174-2184, 2019 | 89 | 2019 |
| The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis MG Oser, AH Sabet, W Gao, AA Chakraborty, AC Schinzel, RB Jennings, ... Genes & development 33 (23-24), 1718-1738, 2019 | 80 | 2019 |
| Renal cell carcinoma in the era of precision medicine: from molecular pathology to tissue-based biomarkers S Signoretti, A Flaifel, YB Chen, VE Reuter Journal of Clinical Oncology 36 (36), 3553, 2018 | 68 | 2018 |
| Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors S Abou Alaiwi, AH Nassar, W Xie, Z Bakouny, JE Berchuck, DA Braun, ... Cancer immunology research 8 (8), 1075-1084, 2020 | 61 | 2020 |
| PD-L1 expression and clinical outcomes to cabozantinib, everolimus, and sunitinib in patients with metastatic renal cell carcinoma: analysis of the randomized clinical trials … A Flaifel, W Xie, DA Braun, M Ficial, Z Bakouny, AH Nassar, RB Jennings, ... Clinical Cancer Research 25 (20), 6080-6088, 2019 | 56 | 2019 |
| Expression of T-cell exhaustion molecules and human endogenous retroviruses as predictive biomarkers for response to nivolumab in metastatic clear cell renal cell carcinoma M Ficial, OA Jegede, M Sant'Angelo, Y Hou, A Flaifel, JC Pignon, ... Clinical Cancer Research 27 (5), 1371-1380, 2021 | 53 | 2021 |
| Testicular changes associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) A Flaifel, M Guzzetta, M Occidental, BB Najari, J Melamed, KM Thomas, ... Archives of pathology & laboratory medicine 145 (1), 8-9, 2021 | 53 | 2021 |
| SARS-CoV-2 is not detected in the cerebrospinal fluid of encephalopathic COVID-19 patients DG Placantonakis, M Aguero-Rosenfeld, A Flaifel, J Colavito, K Inglima, ... Frontiers in Neurology 11, 587384, 2020 | 29 | 2020 |
| Results of a phase II study of atezolizumab and bevacizumab in non-clear cell renal cell carcinoma (nccRCC) and clear cell renal cell carcinoma with sarcomatoid differentiation … RR McKay, BA McGregor, K Gray, JA Steinharter, MK Walsh, DA Braun, ... Journal of Clinical Oncology 37 (7_suppl), 548-548, 2019 | 25 | 2019 |
| Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma A Tripathi, E Lin, W Xie, A Flaifel, JA Steinharter, ENS Gatof, G Bouchard, ... Journal for immunotherapy of cancer 8 (2), 2020 | 22 | 2020 |
| Association of SARS-CoV-2 placental histopathology findings with maternal–fetal comorbidities and severity of COVID-19 hypoxia JA Meyer, AS Roman, M Limaye, TB Grossman, A Flaifel, MJ Vaz, ... The Journal of Maternal-Fetal & Neonatal Medicine 35 (25), 8412-8418, 2022 | 21 | 2022 |
| Atezolizumab plus bevacizumab in non-clear cell renal cell carcinoma (NccRCC) and clear cell renal cell carcinoma with sarcomatoid differentiation (ccRCCsd): Updated results of … R Flippot, BA McGregor, A Flaifel, KP Gray, S Signoretti, JA Steinharter, ... Journal of Clinical Oncology 37 (15_suppl), 4583-4583, 2019 | 15 | 2019 |
| Pulmonary pathology of end-stage COVID-19 disease in explanted lungs and outcomes after lung transplantation A Flaifel, B Kwok, J Ko, S Chang, D Smith, F Zhou, LA Chiriboga, B Zeck, ... American Journal of Clinical Pathology 157 (6), 908-926, 2022 | 14 | 2022 |
| Biomarkers of angiogenesis and clinical outcomes to cabozantinib and everolimus in patients with metastatic renal cell carcinoma from the phase III METEOR trial T Denize, S Farah, A Cimadamore, A Flaifel, E Walton, MA Sticco-Ivins, ... Clinical Cancer Research 28 (4), 748-755, 2022 | 13 | 2022 |
Toni ChoueiriDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
